- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07634796
Development of a Pain Rehabilitation Program for Chronic Pain After SCI
Feasibility of a New Digital Pain Rehabilitation Program for People With SCI
Pain rehabilitation programs are essential for optimal treatment of chronic pain and are usually based on the biopsychosocial model. This is, however, not standard care for people with chronic pain after a spinal cord injury (SCI) due to a biomedical focused perspective of SCI and lack of adapted programs.
The aims of this feasibility study:
- Develop a new digital pain rehabilitation program, adapted for the needs of people living with an SCI.
- To investigate the feasibility and acceptability of a new digital pain rehabilitation program.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study follows the guidelines of Medical Research Council for complex interventions and the proposed iterative feasibility process to improve and prepare the intervention for future testing in an RCT study. The research group will, toghether with a reference groups, develop a digital intervention porposal. The program will be a team-based, goal-oriented program for patients with spinal cord injury (SCI) and chronic pain.
In this study, eligible participants are included in an 8 week pain rehabilitation program. The program is developed through user-involvement i.e. together with clinicians (experienced in pain rehabilitation and/or SCI rehabilitation), stakeholders, researchers and individuals with SCI. The program will include video material for education, home exercises and group discussions led by clinicians with long experience in pain rehabilitation and SCI.
The participants will fill in self-assessed questionaries at baseline and after the finish of the program about their pain, sleep, mood and quality of life. After the program some of the participants will be asked to participate in semi-structured interviews about how they navigate and engage with different components of the program. The patients will be recruited during a rutine follow up at an SCI clinic.
Seven factors will be studied to assess the feasibility and acceptability of the program, based on set goals according to the Traffic Light method.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Gunilla Stenberg, Docent
- Telefonnummer: +46 90 7869895
- E-post: gunilla.stenberg@umu.se
Studera Kontakt Backup
- Namn: Sofia Björkbacka, MSc
- Telefonnummer: 0046907869349
- E-post: sofia.bjorkbacka@umu.se
Studieorter
-
-
-
Umeå, Sverige, 90736
- Inst. Community Medicine and Rehabilitation
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- two years since injury
- Stable pain medication?
Exclusion Criteria:
- severe cognitive impairment
- Alcohol or drug abuse
- does not understand Swedish
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Spinal cord injury (SCI) and chronic pain
People with chronic pain after spinal cord injury
|
8- week pain rehabilitation program.
The first meeting of the program is located at a hospital facility and thereafter they will meet at a digital platform.The program include education, home exercises and group meetings.
The program consists of 4 modules.
1. Physical exercise and ergonomics.
2. Structure and recovery.
3. Employment/occupation and social support.
4. ACT and coping.
Each module lasts for two weeks.
The program will include video material for education, home exercises and group discussions led by clinicians with long experience in pain rehabilitation and SCI.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Recruitment rate, number recruited per quarter
Tidsram: At enrollment
|
Continue=6 Solve=4 Stop=3
|
At enrollment
|
|
Number of participant with treatment-related advere events as assessed by...
Tidsram: From enrollment to the end of tretment at 8 weeks
|
From enrollment to the end of tretment at 8 weeks
|
|
|
Participant retention- Completion rates
Tidsram: The end of the 8- week program
|
>75% continue, 50-75% Solve, <50% stop
|
The end of the 8- week program
|
|
Program Adherence
Tidsram: The end of the 8-week program
|
Continue >75%, solve 50-75%, stop <50%
|
The end of the 8-week program
|
|
Patients' self-perceived relevance, timing and mode of delivery
Tidsram: >70% Continue, Solve 50-70%, Stop <50%
|
Patient evaluation, satisfied patients
|
>70% Continue, Solve 50-70%, Stop <50%
|
|
Assessment procedure acceptance- Patient evaluations, proportions of completed questionnaires
Tidsram: At the end of the 8-week program
|
>80% continue, 50-80% solve, <50% stop
|
At the end of the 8-week program
|
|
Fidelity of delivery - Process evaluations
Tidsram: End of the 8-week program
|
End of the 8-week program
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Smärta
- Neurologiska manifestationer
- Sjukdomar i centrala nervsystemet
- Sjukdomar i nervsystemet
- Sår och skador
- Neuromuskulära sjukdomar
- Sjukdomar i det perifera nervsystemet
- Neurobehavioral manifestationer
- Trauma, nervsystemet
- Ryggmärgssjukdomar
- Perceptuella störningar
- Patologiska tillstånd, tecken och symtom
- Tecken och symtom
- Kronisk smärta
- Neuralgi
- Ryggmärgsskador
- Agnosia
Andra studie-ID-nummer
- 2023-04232-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .